The ALDH18A1 Knockout HEK293T Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HEK293T human embryonic kidney epithelial cell line, engineered to disrupt the ALDH18A1 gene. This polyclonal population consists of cells with heterogeneous gene-disruption events introduced by CRISPR/Cas9, enabling loss-of-function studies without requiring clonal isolation. The targeted gene encodes the bifunctional enzyme pyrroline-5-carboxylate synthase (P5CS), which catalyzes the ATP- and NADPH-dependent conversion of glutamate to ??1-pyrroline-5-carboxylate (P5C), a critical step in the biosynthesis of proline, ornithine, and arginine. Because no single editing outcome is selected, this population retains the genetic diversity inherent to polyclonal knockout models, supporting robust functional analyses while avoiding clonal artifacts.
The HEK293T host cell line is an immortalized derivative of human embryonic kidney 293 cells that stably expresses the SV40 large T antigen. This antigen enhances episomal replication of plasmids containing the SV40 origin of replication, thereby enabling high-level transient protein expression. Widely adopted for recombinant protein production, lentiviral packaging, and biochemical studies, HEK293T cells offer facile transfection, rapid growth, and a well-characterized genetic background. Their epithelial origin and metabolic profile make them particularly suitable for investigating amino acid metabolism and stress-response pathways. In their native state, HEK293T cells are prototrophic for proline, synthesizing it endogenously through the P5CS-dependent pathway; disruption of ALDH18A1 therefore creates a conditionally auxotrophic model that reveals the dependency on de novo proline synthesis.
ALDH18A1 plays a central role in proline metabolism and is tightly integrated with the urea cycle and arginine?Ccitrulline interconversion. The encoded P5CS enzyme functions as a homodimer and is localized to the mitochondrial inner membrane, where it partners with PYCR1, PYCR2, and PYCR3 to recycle proline and with ornithine aminotransferase (OAT) to channel intermediates into ornithine and citrulline production. Transcriptionally, ALDH18A1 is upregulated by the integrated stress response (ISR) mediator ATF4 and by Myc, and is suppressed by p53; its activity is also modulated by nutrient-sensing pathways such as mTORC1. Downstream, P5CS-generated P5C is the obligate precursor for proline, which in turn supplies hydroxyproline for collagen biosynthesis and helps regulate cellular redox balance via the NADPH/NADP+ ratio. Consequently, ablation of P5CS disrupts this metabolic node, triggering proline auxotrophy, impairing mitochondrial function, and activating ATF4-driven stress programs.
In the HEK293T context, ALDH18A1 knockout yields a well-defined proline-auxotrophic phenotype that makes the model invaluable for dissecting the interplay between amino acid availability, stress signaling, and cell proliferation. The engineered cells depend on exogenous proline for survival and growth, enabling precise titration of proline levels in culture to examine dose?Cresponse relationships in proliferation, collagen maturation, and reactive oxygen species (ROS) homeostasis. This system is especially relevant to cancer biology, where metabolic reprogramming often upregulates proline biosynthesis to support tumor growth, and to the study of congenital disorders such as autosomal recessive cutis laxa type IIIA (ARCL3A) and dominant spastic paraplegia 9 (SPG9), both linked to ALDH18A1 mutations. The polyclonal nature of the knockout ensures that results reflect gene-level disruption rather than clone-specific adaptations, thereby increasing confidence in mechanistic conclusions.
This knockout cell model supports a broad range of research applications, from metabolic flux analysis using LC?MS-based metabolomics and Seahorse respirometry to functional complementation assays that rescue the knockout phenotype by re-expressing wild-type or mutant ALDH18A1. Typical experiments include proline-auxotrophy growth assays with and without proline supplementation, Western blotting for ALDH18A1, PYCR1, and ATF4, RT-qPCR profiling of stress-responsive genes, immunofluorescence staining of collagen deposition, and measurement of intracellular ROS levels. The system is also suited for investigating the integrated stress response pathway, particularly ATF4-mediated transcriptional programs, under nutrient-limited conditions. For further information, please contact Ascent Research.
